FULL PRESCRIBING INFORMATION
TO ORDER, PLEASE CONTACT CUSTOMER SERVICE AT 1-866-ARESTIN.
Our flagship product, ARESTIN (minocycline HCl) Microspheres, 1 mg, is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. Clinical studies show that ARESTIN plus SRP achieves greater pocket depth reduction than SRP alone.1
Using advanced microsphere technology, ARESTIN provides sustained release of minocycline, a broad-spectrum antibiotic that targets infection. Currently, ARESTIN is the leading locally administered antibiotic (LAA) for the treatment of periodontitis.2,3
Clinical trial data demonstrate clear benefits from active treatment with ARESTIN plus SRP when indicated to2:
- Target the microorganisms associated with a periodontal infection
- Significantly reduce pocket depth compared to SRP alone
- Help restore a state of periodontal health
- Help restore a healthy balance of bacteria
ARESTIN should not be used in any patient who has a known sensitivity to minocycline or tetracyclines.
REFERENCES: 1. Bland PS, Goodson JM, Gunsolley JC, Grossi SG, Otomo-Corgel J, et al. Association of antimicrobial and clinical efficacy: periodontitis therapy with minocycline microspheres. JIAP. 2010;12(1):11-19. 2. ARESTIN® (minocycline hydrochloride) Microspheres, 1 mg. Prescribing Information. OraPharma; Bridgewater, NJ. 3. Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol. 2001;72(11):1535-1544.